Primary non-Hodgkin's lymphoma of the right atrium presenting as a cardiac mass: surgical debulking followed by chemotherapy.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
surgical debulking
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
This case underscores the importance of including PCL in the differential diagnosis of right atrial masses. Early imaging, prompt tissue diagnosis, and chemotherapy can lead to excellent outcomes even in aggressive disease presentations.
Primary cardiac lymphoma (PCL) is a rare malignancy, representing less than 1% of primary cardiac tumors.
APA
Mukherjee S, Kumar RM, et al. (2025). Primary non-Hodgkin's lymphoma of the right atrium presenting as a cardiac mass: surgical debulking followed by chemotherapy.. Indian journal of thoracic and cardiovascular surgery, 41(12), 1809-1814. https://doi.org/10.1007/s12055-025-02084-6
MLA
Mukherjee S, et al.. "Primary non-Hodgkin's lymphoma of the right atrium presenting as a cardiac mass: surgical debulking followed by chemotherapy.." Indian journal of thoracic and cardiovascular surgery, vol. 41, no. 12, 2025, pp. 1809-1814.
PMID
41281403 ↗
Abstract 한글 요약
Primary cardiac lymphoma (PCL) is a rare malignancy, representing less than 1% of primary cardiac tumors. While benign tumors like myxomas more commonly affect the left atrium, malignant lesions-particularly lymphomas and angiosarcomas-typically involve the right atrium. The nonspecific presentation often delays diagnosis and treatment. A 40-year-old male presented with progressive dyspnea, chest pain, fatigue, and pedal edema. Transthoracic and transesophageal echocardiography revealed a large right atrial mass with pericardial effusion. Cardiac magnetic resonance imaging (MRI) showed a heterogeneous mass with peripheral enhancement and central necrosis, initially suggestive of angiosarcoma. Due to inconclusive biopsy findings, the patient underwent surgical debulking. Histopathological analysis confirmed diffuse large B-cell lymphoma (DLBCL) (non-germinal center type) with CD20 positivity and a high Ki-67 index. Postoperative positron emission tomography (PET) scan showed residual mediastinal involvement. The patient received six cycles of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy with intrathecal methotrexate. Follow-up positron emission tomography-computed tomography (PET CT) demonstrated complete metabolic remission, corroborated by echocardiography. This case underscores the importance of including PCL in the differential diagnosis of right atrial masses. Early imaging, prompt tissue diagnosis, and chemotherapy can lead to excellent outcomes even in aggressive disease presentations.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- A Datasheet for Age-Related Eye Disease Study 2 on the Database of Genotypes and Phenotypes.
- Artificial intelligence powered mobile health apps for skin cancer detection: current challenges and a systems thinking approach for improved public health outcomes in low- and middle-income countries.
- Imaging of Laryngeal and Hypopharyngeal Squamous Cell Cancers.
- Hemorrhagic Cardiac Tamponade Due to MRSA Sepsis in a Child with Relapsed Acute Lymphoblastic Leukemia.
- Human Fidgetin Modulates Cell Migration and EMT in Breast Cancer Cells.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A novel real-world data methodology for lymphoma outcome classification: the real-world Lugano study.
- Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton's tyrosine kinase inhibitor and bispecific antibody therapy.
- Case Report: Application of multimodal imaging in the diagnosis and treatment evaluation of primary cardiac lymphoma.
- Breast Implant-Associated Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma.
- Prognostic Value of the CALLY Index in Diffuse Large B-Cell Lymphoma: Linking Inflammation, Nutrition, and Tumor Biology.
- Nuclear receptor subfamily 2 group F member 2 transcriptionally activates 14-3-3 epsilon to promote diffuse large B-cell lymphoma progression.